• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

综述:作为抗感染药物的 1,2,4-噁二唑的合成研究。

A review on synthetic account of 1,2,4-oxadiazoles as anti-infective agents.

机构信息

L. M. College of Pharmacy, Navrangpura, Ahmedabad, Gujarat, 380 009, India.

出版信息

Mol Divers. 2022 Oct;26(5):2967-2980. doi: 10.1007/s11030-021-10375-4. Epub 2022 Jan 5.

DOI:10.1007/s11030-021-10375-4
PMID:34984590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8727175/
Abstract

Most of the currently marketed drugs consist of heterocyclic scaffolds containing nitrogen and or oxygen as heteroatoms in their structures. Several research groups have synthesized diversely substituted 1,2,4-oxadiazoles as anti-infective agents having anti-bacterial, anti-viral, anti-leishmanial, etc. activities. For the first time, the present review article will provide the coverage of synthetic account of 1,2,4-oxadiazoles as anti-infective agents along with their potential for SAR, activity potential, promising target for mode of action. The efforts have been made to provide the chemical intuitions to the reader to design new chemical entity with potential of anti-infective activity. This review will mark the impact as the valuable, comprehensive and pioneered work along with the library of synthetic strategies for the organic and medicinal chemists for further refinement of 1,2,4-oxadiazole as anti-infective agents.

摘要

目前市场上销售的大多数药物都含有杂环支架,其结构中含有氮和/或氧作为杂原子。一些研究小组已经合成了多种取代的 1,2,4-恶二唑作为具有抗细菌、抗病毒、抗利什曼原虫等活性的抗感染药物。本文首次综述了 1,2,4-恶二唑作为抗感染药物的合成研究进展,以及它们的构效关系、活性潜力、有希望的作用机制靶点。本文旨在为读者提供化学直觉,以设计具有抗感染活性的新化学实体。这项研究具有重要意义,是一项全面而开创性的工作,为有机和药物化学家提供了 1,2,4-恶二唑作为抗感染药物的合成策略库,为进一步改进提供了支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/a34732300535/11030_2021_10375_Sch15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/1a260f0158c9/11030_2021_10375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/14a41d7286d7/11030_2021_10375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/c6808491fb72/11030_2021_10375_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/8b7853ee0448/11030_2021_10375_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/3cda26106664/11030_2021_10375_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/beceea2b67a4/11030_2021_10375_Sch2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/399d684d2f8e/11030_2021_10375_Sch3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/c14c3d950503/11030_2021_10375_Sch4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/4e642c6ca9bd/11030_2021_10375_Sch5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/ee4ab444b4d5/11030_2021_10375_Sch6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/a2a4130308a2/11030_2021_10375_Sch7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/828dd7da8efe/11030_2021_10375_Sch8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/8bdc6c5905b6/11030_2021_10375_Sch9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/647b1e8052e7/11030_2021_10375_Sch10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/8672edd82eba/11030_2021_10375_Sch11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/244cd05afca4/11030_2021_10375_Sch12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/1ef5d7d755d5/11030_2021_10375_Sch13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/a5017b0ad7ba/11030_2021_10375_Sch14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/a34732300535/11030_2021_10375_Sch15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/1a260f0158c9/11030_2021_10375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/14a41d7286d7/11030_2021_10375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/c6808491fb72/11030_2021_10375_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/8b7853ee0448/11030_2021_10375_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/3cda26106664/11030_2021_10375_Sch1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/beceea2b67a4/11030_2021_10375_Sch2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/399d684d2f8e/11030_2021_10375_Sch3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/c14c3d950503/11030_2021_10375_Sch4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/4e642c6ca9bd/11030_2021_10375_Sch5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/ee4ab444b4d5/11030_2021_10375_Sch6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/a2a4130308a2/11030_2021_10375_Sch7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/828dd7da8efe/11030_2021_10375_Sch8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/8bdc6c5905b6/11030_2021_10375_Sch9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/647b1e8052e7/11030_2021_10375_Sch10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/8672edd82eba/11030_2021_10375_Sch11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/244cd05afca4/11030_2021_10375_Sch12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/1ef5d7d755d5/11030_2021_10375_Sch13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/a5017b0ad7ba/11030_2021_10375_Sch14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f163/8727175/a34732300535/11030_2021_10375_Sch15_HTML.jpg

相似文献

1
A review on synthetic account of 1,2,4-oxadiazoles as anti-infective agents.综述:作为抗感染药物的 1,2,4-噁二唑的合成研究。
Mol Divers. 2022 Oct;26(5):2967-2980. doi: 10.1007/s11030-021-10375-4. Epub 2022 Jan 5.
2
Recent updates on biological activities of oxadiazoles.恶二唑类化合物的生物活性研究进展。
Mini Rev Med Chem. 2013 Jun;13(7):1027-46. doi: 10.2174/1389557511313070007.
3
A comprehensive review of recent advances in the biological activities of 1,2,4-oxadiazoles.1,2,4-噁二唑类化合物生物活性的最新研究进展综述。
Arch Pharm (Weinheim). 2022 Jul;355(7):e2200045. doi: 10.1002/ardp.202200045. Epub 2022 Apr 21.
4
Synthesis and biological property of some novel 1,3,4-oxadiazoles.一些新型 1,3,4-噁二唑的合成与生物活性。
Eur J Med Chem. 2010 Oct;45(10):4587-93. doi: 10.1016/j.ejmech.2010.07.021. Epub 2010 Aug 12.
5
1,3,4-oxadiazole derivatives as potential biological agents.1,3,4-噁二唑衍生物作为潜在的生物制剂。
Mini Rev Med Chem. 2013 Oct;13(12):1725-43. doi: 10.2174/13895575113139990071.
6
Synthesis and Biological Activities of Oxadiazole Derivatives: A Review.恶二唑衍生物的合成与生物活性:综述
Mini Rev Med Chem. 2016;16(10):825-45. doi: 10.2174/1389557516666160211120835.
7
Antimicrobial Activity of 1,3,4-Oxadiazole Derivatives.1,3,4-恶二唑衍生物的抗菌活性。
Int J Mol Sci. 2021 Jun 29;22(13):6979. doi: 10.3390/ijms22136979.
8
Antimicrobial studies of 2,4-dichloro-5-fluorophenyl containing oxadiazoles.含1,3,4-恶二唑的2,4-二氯-5-氟苯基的抗菌研究。
Eur J Med Chem. 2008 Jan;43(1):25-31. doi: 10.1016/j.ejmech.2007.03.013. Epub 2007 Apr 3.
9
A Review of the Biological Activities of Heterocyclic Compounds Comprising Oxadiazole Moieties.含恶二唑部分的杂环化合物的生物活性研究综述。
Curr Top Med Chem. 2022;22(7):578-599. doi: 10.2174/1568026622666220202123651.
10
Anti-inflammatory and Antimicrobial Potential of 1, 3, 4-oxadiazoles and its Derivatives: A Review.1,3,4-噁二唑及其衍生物的抗炎和抗菌潜力:综述。
Curr Org Synth. 2024;21(8):1014-1020. doi: 10.2174/0115701794265887231014061317.

引用本文的文献

1
Structural, CSD, Molecular Docking, Molecular Dynamics, and Hirshfeld Surface Analysis of a New Mesogen, Methyl-4-(5-(4-(octyloxy)phenyl)-1,2,4-oxadiazol-3-yl)benzoate.新型介晶化合物4-(5-(4-(辛氧基)苯基)-1,2,4-恶二唑-3-基)苯甲酸甲酯的结构、电荷转移光谱、分子对接、分子动力学及 Hirshfeld 表面分析
ACS Omega. 2025 Jan 28;10(5):4336-4352. doi: 10.1021/acsomega.4c06520. eCollection 2025 Feb 11.
2
1,2,4-Oxadiazole Derivatives: Physicochemical Properties, Antileishmanial Potential, Docking and Molecular Dynamic Simulations of Target Proteins.1,2,4-恶二唑衍生物:理化性质、抗利什曼原虫活性、靶蛋白对接和分子动力学模拟。
Molecules. 2024 Sep 30;29(19):4654. doi: 10.3390/molecules29194654.
3

本文引用的文献

1
A decennary update on applications of metal nanoparticles (MNPs) in the synthesis of nitrogen- and oxygen-containing heterocyclic scaffolds.金属纳米颗粒(MNPs)在含氮和含氧杂环骨架合成中的应用十年进展。
RSC Adv. 2020 Sep 3;10(54):32740-32820. doi: 10.1039/d0ra02272a. eCollection 2020 Sep 1.
2
In search of SARS CoV-2 replication inhibitors: Virtual screening, molecular dynamics simulations and ADMET analysis.寻找严重急性呼吸综合征冠状病毒2复制抑制剂:虚拟筛选、分子动力学模拟及药物代谢动力学/药物毒性预测分析
J Mol Struct. 2021 Dec 15;1246:131190. doi: 10.1016/j.molstruc.2021.131190. Epub 2021 Jul 26.
3
In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis.
Molecular Periphery Design Allows Control of the New Nitrofurans Antimicrobial Selectivity.
分子外围设计可控制新型硝基呋喃类抗生素的抗菌选择性。
Molecules. 2024 Jul 17;29(14):3364. doi: 10.3390/molecules29143364.
4
Design, Synthesis, Antifungal Activity, and 3D-QSAR Study of Novel Quinoxaline-2-Oxyacetate Hydrazide.新型喹喔啉-2-氧基乙酸腙的设计、合成、抗真菌活性及 3D-QSAR 研究。
Molecules. 2024 May 25;29(11):2501. doi: 10.3390/molecules29112501.
5
Synthetic account on indoles and their analogues as potential anti-plasmodial agents.关于吲哚及其类似物作为潜在抗疟原虫药物的综合论述。
Mol Divers. 2025 Feb;29(1):871-897. doi: 10.1007/s11030-024-10842-8. Epub 2024 May 6.
6
Design, synthesis, anti-mycobacterial activity, molecular docking and ADME analysis of spiroquinoxaline-1,2,4-oxadiazoles via [3 + 2] cycloaddition reaction under ultrasound irradiation.超声辐射下通过[3 + 2]环加成反应设计、合成、抗分枝杆菌活性、分子对接及药物代谢动力学分析螺喹喔啉-1,2,4-恶二唑
Mol Divers. 2024 Dec;28(6):3979-3991. doi: 10.1007/s11030-023-10790-9. Epub 2024 Jan 23.
7
Novel Hydroxamic Acids Containing Aryl-Substituted 1,2,4- or 1,3,4-Oxadiazole Backbones and an Investigation of Their Antibiotic Potentiation Activity.含芳基取代的 1,2,4-或 1,3,4-噁二唑骨架的新型偕羟肟酸及其抗生素增效活性的研究。
Int J Mol Sci. 2023 Dec 20;25(1):96. doi: 10.3390/ijms25010096.
8
Modes of Action of a Novel c-MYC Inhibiting 1,2,4-Oxadiazole Derivative in Leukemia and Breast Cancer Cells.新型 c-MYC 抑制 1,2,4-恶二唑衍生物在白血病和乳腺癌细胞中的作用机制。
Molecules. 2023 Jul 26;28(15):5658. doi: 10.3390/molecules28155658.
9
Synthesis, modelling, and biological evaluation of substituted pyrazole derivatives as potential anti-skin cancer, anti-tyrosinase, and antioxidant agents.合成、建模及取代吡唑衍生物的生物评价作为潜在的抗皮肤癌、酪氨酸酶抑制剂和抗氧化剂。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):2205042. doi: 10.1080/14756366.2023.2205042.
10
Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles.室温下合成生物活性 1,2,4-噁二唑。
Int J Mol Sci. 2023 Mar 12;24(6):5406. doi: 10.3390/ijms24065406.
寻找针对严重急性呼吸综合征冠状病毒2(SARS CoV-2)的RNA依赖性RNA聚合酶(RdRp)和主要蛋白酶(Mpro)抑制剂:分子对接、分子动力学模拟及药物代谢动力学/药物毒性预测分析
J Mol Struct. 2021 Sep 5;1239:130488. doi: 10.1016/j.molstruc.2021.130488. Epub 2021 Apr 21.
4
Green Synthetic Approach: An Efficient Eco-Friendly Tool for Synthesis of Biologically Active Oxadiazole Derivatives.绿色合成方法:一种高效环保的生物活性噁二唑衍生物合成工具。
Molecules. 2021 Feb 22;26(4):1163. doi: 10.3390/molecules26041163.
5
Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.苯并[d]咪唑-2-甲酰胺类衍生物的设计、合成与抗结核活性评价
Bioorg Chem. 2021 Feb;107:104538. doi: 10.1016/j.bioorg.2020.104538. Epub 2020 Dec 10.
6
Design, synthesis and molecular modeling of novel aryl carboximidamides and 3-aryl-1,2,4-oxadiazoles derived from indomethacin as potent anti-inflammatory iNOS/PGE2 inhibitors.新型芳基碳酰亚胺和 3-芳基-1,2,4-恶二唑的设计、合成及分子模拟,这些化合物来源于吲哚美辛,具有强效抗炎 iNOS/PGE2 抑制作用。
Bioorg Chem. 2020 Dec;105:104439. doi: 10.1016/j.bioorg.2020.104439. Epub 2020 Oct 28.
7
Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents.设计和合成 3-(4-吡啶基)-5-(4-磺胺基苯基)-1,2,4-恶二唑衍生物作为新型 GSK-3β 抑制剂,并评估它们作为多功能抗阿尔茨海默病药物的潜力。
Eur J Med Chem. 2021 Jan 1;209:112874. doi: 10.1016/j.ejmech.2020.112874. Epub 2020 Sep 28.
8
Design and synthesis of 3,5-substituted 1,2,4-oxadiazoles as catalytic inhibitors of human DNA topoisomerase IIα.设计和合成 3,5-取代的 1,2,4-噁二唑类化合物作为人源拓扑异构酶 IIα 的催化抑制剂。
Bioorg Chem. 2020 Jun;99:103828. doi: 10.1016/j.bioorg.2020.103828. Epub 2020 Apr 8.
9
Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation.苯并咪唑并喹唑啉类作为新型有效的抗结核化学类型:设计、合成与生物评价。
Bioorg Chem. 2020 Jun;99:103774. doi: 10.1016/j.bioorg.2020.103774. Epub 2020 Mar 19.
10
Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy.新型 1,2,4-噁二唑-磺酰胺类化合物的合成及构效关系研究作为结直肠癌治疗的潜在抗癌药物。
Bioorg Chem. 2020 May;98:103754. doi: 10.1016/j.bioorg.2020.103754. Epub 2020 Mar 13.